PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
354 hedge funds and large institutions have $7.26B invested in PRA Health Sciences, Inc. in 2019 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 149 increasing their positions, 105 reducing their positions, and 32 closing their positions.
72% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 32
42% more repeat investments, than reductions
Existing positions increased: 149 | Existing positions reduced: 105
21% more capital invested
Capital invested by funds: $6B → $7.26B (+$1.27B)
6% more funds holding
Funds holding: 334 → 354 (+20)
32% less call options, than puts
Call options by funds: $41.3M | Put options by funds: $60.9M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$62.5M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$54.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$39.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$30.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$137M |
| 2 |
Bank of New York Mellon
New York
|
-$70M |
| 3 |
Millennium Management
New York
|
-$60.8M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$23.2M |
| 5 |
Jennison Associates
New York
|
-$18.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ECM
376
ExodusPoint Capital Management
New York
| – | -$244K | -2,651 | Closed |
|
|
OSAM
377
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$222K | -2,405 | Closed |
|
|
IAM
378
Integre Asset Management
New York
| – | -$214K | -2,324 | Closed |
|
|
ER
379
Enlightenment Research
Miami,
Florida
| – | -$101K | -1,100 | Closed |
|
|
JA
380
JOYN Advisors
Atlanta,
Georgia
| – | -$14K | -155 | Closed |
|
381
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$9K | -100 | Closed |
|
|
CCA
382
Catalyst Capital Advisors
Huntington,
New York
| – | -$8K | -86 | Closed |
|
|
MPWT
383
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| – | -$3.86K | -42 | Closed |
|
|
SGS
384
Sterling Global Strategies
Carlsbad,
California
| – | -$2.94K | -32 | Closed |
|
|
PWMG
385
Prestige Wealth Management Group
Flemington,
New Jersey
| – | -$1K | -6 | Closed |
|
PRAH Hedge Fund Activity: Q1 2019 in Review
354 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q1 2019, worth a combined $7.26B — up 21% from $6B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new PRAH positions and 32 closed out — a net gain of 23 holders — while 149 added to existing stakes and 105 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $62.5M. The largest seller was DZ Bank, cutting an estimated $137M.
- 354 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q1 2019, up from 334 in Q4 2018.
- Funds reported $7.26B of PRA Health Sciences, Inc. stock for Q1 2019, up 21% quarter-over-quarter.
- 55 funds opened new PRA Health Sciences, Inc. positions in Q1 2019 and 32 closed out, a net change of +23 holders.
- The largest PRA Health Sciences, Inc. buyer in Q1 2019 was AQR Capital Management, an estimated $62.5M added.
- The largest PRA Health Sciences, Inc. seller in Q1 2019 was DZ Bank, an estimated $137M sold.
Based on aggregated 13F filings for Q1 2019.